|
Vol. 10, Issue 8, 1219-1229, August 2000
METHODS
High-resolution Quantification of Specific mRNA Levels in Human Brain Autopsies and Biopsies
Anja
Castensson,1
Lina
Emilsson,1
Paul
Preece,2 and
and Elena
Jazin1,3
1 Section of Medical Genetics, Department of Genetics and
Pathology, Rudbeck Laboratory, Uppsala University, S-751 85 Uppsala,
Sweden; 2 University College London, MRC Laboratory for Molecular
Cell Biology and Department of Pharmacology, London WC1E 6BT, England
Quantification of mRNA levels in human cortical brain biopsies and
autopsies was performed using a fluorogenic 5' nuclease assay. The
reproducibility of the assay using replica plates was 97%-99%.
Relative quantities of mRNA from 16 different genes were evaluated
using a statistical approach based on ANCOVA analysis. Comparison of
the relative mRNA levels between two groups of samples with different
time postmortem revealed unchanged relative expression levels for most
genes. Only CYP26A1 mRNA levels showed a significant decrease with
prolonged time postmortem (p = 0.00004). Also, there was a general
decrease in measured mRNA levels for all genes in autopsies compared to
biopsies; however, on comparing mRNA levels after adjusting with
reference genes, no significant differences were found between mRNA
levels in autopsies and biopsies. This observation indicates that
studies of postmortem material can be performed to reveal the relative
in vivo mRNA levels of genes. Power calculations were done to determine
the number of individuals necessary to detect differences in mRNA
levels of 1.5-fold to tenfold using the strategy described here. This
analysis showed that samples from at least 50 individuals per group,
patients and controls, are required for high-resolution (~twofold
changes) differential expression screenings in the human brain.
Experiments done on ten individuals per group will result in a
resolution of ~fivefold changes in expression levels. In general,
the sensitivity and resolution of any differential expression study
will depend on the sample size used and the between-individual
variability of the genes analyzed.
3
Corresponding author.
10:1219-1229 ©2000 by Cold Spring Harbor Laboratory Press ISSN 1088-9051/00 $5.00

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Al'Qteishat, J. Gaffney, J. Krupinski, F. Rubio, D. West, S. Kumar, P. Kumar, N. Mitsios, and M. Slevin
Changes in hyaluronan production and metabolism following ischaemic stroke in man
Brain,
August 1, 2006;
129(8):
2158 - 2176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Aberg, P. Saetre, N. Jareborg, and E. Jazin
Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia
PNAS,
May 9, 2006;
103(19):
7482 - 7487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K E Wilson, M M Ryan, J E Prime, D P Pashby, P R Orange, G O'Beirne, J G Whateley, S Bahn, and C M Morris
Functional genomics and proteomics: application in neurosciences
J. Neurol. Neurosurg. Psychiatry,
April 1, 2004;
75(4):
529 - 538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Z. Li, M. P. Vawter, D. M. Walsh, H. Tomita, S. J. Evans, P. V. Choudary, J. F. Lopez, A. Avelar, V. Shokoohi, T. Chung, et al.
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions
Hum. Mol. Genet.,
March 15, 2004;
13(6):
609 - 616.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|